Veraxa Biotech Eyes Nasdaq Listing Through SPAC Merger
Deal News | May 06, 2025 | Legal Community Swiss
In a strategic move expected to elevate its market presence, Zurich-based Veraxa Biotech has signed a merger agreement with Voyager Acquisition Corp, a Cayman Islands-listed Special Purpose Acquisition Company (SPAC). The transaction, announced on April 23, 2025, places Veraxa's valuation at up to USD 1.64 billion. This merger aims to position Veraxa as a Nasdaq-listed entity by the fourth quarter of 2025. The Swiss law firm Walder Wyss is advising Veraxa Biotech on this significant transaction. Key figures from the law firm, including partners Marius Breier and Thiemo Sturny, are leading the advisory team. The transaction involves complex considerations across corporate, tax, and employment law, highlighting the sophisticated legal and strategic intricacies involved in SPAC mergers.
Sectors
- Biotechnology
- Financial Services
- Legal Services
Geography
- Switzerland – Veraxa Biotech is based in Zurich, Switzerland, which is its headquarters and operational base.
- Cayman Islands – Voyager Acquisition Corp is a SPAC incorporated in the Cayman Islands, a common jurisdiction for such entities owing to its favorable regulatory environment.
Industry
- Biotechnology – Veraxa Biotech operates in the biotechnology sector, focusing on the development and commercialization of biotechnological innovations.
- Financial Services – Special Purpose Acquisition Companies (SPACs) like Voyager Acquisition Corp are part of the financial services sector, facilitating capital raising and investment through public listings.
- Legal Services – Walder Wyss, a law firm providing legal advisement on the merger, plays a crucial role in facilitating corporate transactions and regulatory compliance.
Financials
- USD 1.64 billion – Valuation of Veraxa Biotech in the merger with Voyager Acquisition Corp.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Veraxa Biotech | Target Company | Company | A biotech company based in Zurich, aiming to go public via a SPAC merger. |
| Voyager Acquisition Corp | Bidding Company | Company | A publicly traded SPAC incorporated in the Cayman Islands aiming to merge with Veraxa Biotech. |
| Walder Wyss | Legal Advisor | Company | A Swiss law firm advising Veraxa Biotech on its SPAC merger with Voyager Acquisition Corp. |
| Marius Breier | Partner | Person | Partner at Walder Wyss, specializing in tax, leading the legal team for the merger. |
| Thiemo Sturny | Partner | Person | Partner at Walder Wyss, specializing in corporate/M&A, co-leading the legal team. |